{"product_id":"cst-2689s","title":"CST,  2689S, Phospho-IKK gamma (Ser376) Antibody","description":"Polyclonal Antibody for studying IKK-gamma (Ser376) phosphate. Validated for Western Blotting. Highly specific and rigorously validated in-house, Phospho-IKK gamma (Ser376) Antibody (CST #2689) is ready to ship.\n\n\u003cb\u003eProduct Usage Information\u003c\/b\u003e\nWestern Blotting: 1:1000\n\u003cb\u003eStorage\u003c\/b\u003e\nSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg\/ml BSA and 50% glycerol. Store at -20°C. Do not aliquot the antibody.\n\u003cb\u003eProtocol\u003c\/b\u003e\nAvailable protocols: Western Blotting\n\u003cb\u003eSpecificity \/ Sensitivity\u003c\/b\u003e\nPhospho-IKK gamma (Ser376) Antibody detects endogenous levels of IKKÎ³ protein only when phosphorylated at Ser376.\nSpecies Reactivity: Human\n\u003cb\u003eSource \/ Purification\u003c\/b\u003e\nPolyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser376 of human IKKÎ³ protein. Antibodies are purified by protein A and peptide affinity chromatography.\n\u003cb\u003eBackground\u003c\/b\u003e\nThe NF-ÎºB\/Rel transcription factors are present in the cytosol in an inactive state, complexed with the inhibitory IÎºB proteins (1-3). Most agents that activate NF-ÎºB do so through a common pathway based on phosphorylation-induced, proteasome-mediated degradation of IÎºB (3-7). The key regulatory step in this pathway involves activation of a high molecular weight IÎºB kinase (IKK) complex whose catalysis is generally carried out by three tightly associated IKK subunits. IKKÎ± and IKKÎ² serve as the catalytic subunits of the kinase and IKKÎ³ serves as the regulatory subunit (8,9). Activation of IKK depends upon phosphorylation at Ser177 and Ser181 in the activation loop of IKKÎ² (Ser176 and Ser180 in IKKÎ±), which causes conformational changes, resulting in kinase activation (10-13). Activation of the NF-ÎºB pathway by the T-cell lymphotrophic virus Tax protein or by TNF-Î± treatment leads to IKKÎ²-dependent phosphorylation of human IKKÎ³ primarily at Ser376 (14). In mouse, mutation of the orthologous residue (Ser369) to alanine leads to enhanced IKKÎ³-mediated stimulation of IKKÎ² kinase activity (15).\n\u003cb\u003eAlternate Names\u003c\/b\u003e\nAMCBX1; EDAID1; FIP-3; FIP3; Fip3p; I-kappa-B kinase subunit gamma; IkB kinase gamma subunit; IkB kinase subunit gamma; IkB kinase-associated protein 1; IKBKG; IKK-gamma; IKKAP1; IKKG; IMD33; incontinentia pigmenti; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma; inhibitor of nuclear factor kappa B kinase subunit gamma; Inhibitor of nuclear factor kappa-B kinase subunit gamma; IP; IP1; IP2; IPD2; NEMO; NF-kappa-B essential modifier; NF-kappa-B essential modulator; NFkappaB essential modulator; ZC2HC9\n\n\u003cb\u003eSpecification\u003c\/b\u003e\n\nREACTIVITY: H\nSENSITIVITY: Endogenous\nMW (kDa): 50\nSOURCE: Rabbit","brand":"CST","offers":[{"title":"Default Title","offer_id":46797941702825,"sku":"2689S","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/cst-2689s","provider":"Iright","version":"1.0","type":"link"}